Zogenix
+$0.42 (+1.60%) Today
$0.00 (0.00%) As of 11:50 PM UTC after-hours
Why Robinhood?
You can watch Zogenix and buy or sell other stocks, options, and ETFs commission-free!
About ZGNX
At Zogenix, our core strategy is to develop and commercialize differentiated central nervous system (CNS) and pain therapeutics that can address significant unmet medical needs or overcome limitations of existing products. We are a specialty pharmaceutical company with two proprietary product candidates in late-stage development for the treatment of central nervous system disorders and pain.
CEO
Stephen James Farr, PhD
Employees
327
Headquarters
Emeryville, California
Founded
2006
ZGNX Key Statistics
Market cap
1.50B
Price-Earnings ratio
—
Dividend yield
—
Average volume
3.46M
High today
—
Low today
—
Open price
—
Volume
0.00
52 Week high
$26.90
52 Week low
$11.03
ZGNX Earnings
-$1.26
-$0.84
-$0.42
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours